IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Revance Therapeutics Inc (RVNCEUR)

CUSIP: 761330109 | XS | 642 institutional holders

Quarters

Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2025

DekaBank Deutsche Girozentrale86,100
0.0% of portfolio›$425
IFP Advisors, Inc0
0.0% of portfolio›$44
StyleTurnoverLocationFiled
DekaBank Deutsche Girozentrale
86,100$4250.0%CoreLowFrankfurt, Hong Kong2025-04-30
IFP Advisors, Inc
0$440.0%GrowthLowTampa, FL2025-05-05